Stock Events

Stock Events

Harvard Bioscience 

0
38
+€0.00+0% 00:00 Today

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

10NovExpected
Q1 2026
Q2 2026
Next
-0.53
-0.39
-0.26
-0.12
Expected EPS
-0.1463666
Actual EPS
N/A

Financials

-69.03%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
75.25MRevenue
-51.94MNet Income

Analyst Ratings

5.69Average Price Target
The highest estimate is 5.69.
From 1 ratings within the last 6 months. This is not an investment recommendation.
Buy
0%
Hold
100%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow HBI0.STU. It's not an investment recommendation.
Microsoft
8
MSFT
Apple
7
AAPL
Amazon
7
AMZN
Alphabet
7
GOOGL

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Thermo Fisher Scientific
TMO
Mkt Cap226.94B
Thermo Fisher Scientific offers a broad range of products for the life sciences industry, overlapping with Harvard Bioscience's offerings in laboratory equipment and consumables.
Danaher
DHR
Mkt Cap145.98B
Danaher Corporation operates in similar segments as Harvard Bioscience, including life sciences and diagnostics, making them direct competitors in several markets.
Bio-Rad Laboratories
BIO
Mkt Cap10.32B
Bio-Rad Laboratories provides instruments and consumables in the life science research and clinical diagnostics markets, competing directly with Harvard Bioscience's product lines.
Agilent Technologies
A
Mkt Cap42.53B
Agilent Technologies offers products and services for the life sciences, diagnostics, and applied chemical markets, making it a competitor in areas overlapping with Harvard Bioscience's focus.
Waters
WAT
Mkt Cap40.22B
Waters Corporation specializes in analytical instruments for the life sciences sector, directly competing with Harvard Bioscience in the laboratory equipment market.
Bruker
BRKR
Mkt Cap8.91B
Bruker Corporation offers scientific instruments and analytical and diagnostic solutions, competing with Harvard Bioscience in the life science research tools sector.
Bio-Rad Laboratories
BIO.B
Mkt Cap8.84B
Bio-Rad Laboratories, through its Class B shares, represents another avenue of competition in the life sciences and diagnostics markets, directly challenging Harvard Bioscience's offerings.
Mettler-Toledo International
MTD
Mkt Cap26.95B
Mettler-Toledo International offers precision instruments and services for professional use, competing with Harvard Bioscience in the laboratory equipment and analytical instruments sector.
Repligen
RGEN
Mkt Cap9.46B
Repligen Corporation provides bioprocessing technologies and solutions, which competes with Harvard Bioscience's offerings in the life sciences research and clinical diagnostics fields.

About

Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, products, and services that enable advances in life science applications, including research, drug and therapy discovery, bioproduction, and preclinical testing. The company organizes its product line into two product families: Cellular and Molecular Technologies (CMT) and Preclinical. The CMT product family supports molecular, cellular, organ, and organoid research, as well as bioproduction and in vitro testing, while the Preclinical product family provides products for preclinical research and testing, including data collection and analysis for safety and regulatory compliance. Its geographical segments include the Americas, Europe, Middle East and Africa, and Asia.
Show more...
CEO
John D. Duke
Employees
339
Country
United States
ISIN
US4169062043
WKN
000A423J5

Listings

STU
DE
HBI0.STU
MU
DE
HBI0.MU
XNAS
US
HBIO
BOATS
BOATS
HBIO.BOATS

0 Comments

Share your thoughts

FAQ

What is Harvard Bioscience stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Stuttgart exchange Harvard Bioscience stocks are traded under the ticker HBI0.STU.
When is the next Harvard Bioscience earnings date?▼
Harvard Bioscience is going to release the next earnings report on November 10, 2026.
What were Harvard Bioscience earnings last quarter?▼
HBI0.STU earnings for the last quarter are -0.12 EUR per share, whereas the estimation was -0.18 EUR resulting in a +33.33% surprise. The estimated earnings for the next quarter are N/A EUR per share.
What is Harvard Bioscience revenue for the last year?▼
Harvard Bioscience revenue for the last year amounts to 75.25M EUR.
What is Harvard Bioscience net income for the last year?▼
HBI0.STU net income for the last year is -51.94M EUR.
How many employees does Harvard Bioscience have?▼
As of September 07, 2026, the company has 339 employees.
In which sector is Harvard Bioscience located?▼
Harvard Bioscience operates in the Health & Wellness sector.
When did Harvard Bioscience complete a stock split?▼
The last stock split for Harvard Bioscience was on March 16, 2026 with a ratio of 1:10.
Where is Harvard Bioscience headquartered?▼
Harvard Bioscience is headquartered in HOLLISTON, United States.